Jay T. Backstrom insider trades

Open-market stock purchases and sales by Jay T. Backstrom, Director at Agios Pharmaceuticals, Inc, from SEC Form 4 filings since Jan 2, 2020.

Recent trades

DateStockTradeValue
Jul 8, 2026AGIO Agios Pharmaceuticals, IncBought (not open market)—
Jul 8, 2026AGIO Agios Pharmaceuticals, IncBought (not open market)—
Jun 18, 2026AGIO Agios Pharmaceuticals, IncBought (not open market)—
Jun 18, 2026AGIO Agios Pharmaceuticals, IncBought (not open market)—
Nov 13, 2025LVTX LAVA Therapeutics NVSold (not open market)—

Companies traded

  • AGIO Agios Pharmaceuticals, Inc: other filings, last Jul 8, 2026
  • LVTX LAVA Therapeutics NV: other filings, last Nov 13, 2025
  • SRRK Scholar Rock Holding Corp: 3 sales, last Mar 10, 2025
  • IRON Disc Medicine, Inc: other filings, last Dec 29, 2022
  • XLRN Acceleron Pharma Inc: other filings, last Nov 19, 2021

Get free alerts when Jay T. Backstrom files a new trade →